Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Continuous flow reactors for drug discovery.

Paul Watts1, Stephen J Haswell

  • 1Department of Chemistry, University of Hull, Cottingham Road, Hull, UK HU6 7RX. P.Watts@hull.ac.uk

Drug Discovery Today
|July 10, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Developing a digital ecological momentary assessment tool for 'real time' evaluation in implementation science: testing through evaluation of a novel digital social prescribing intervention.

Frontiers in public health·2026
Same author

Protocol of ASPro-PD: a phase 3 trial of ambroxol to slow progression in genetically stratified Parkinson's disease.

Journal of neurology·2026
Same author

An Umbrella Review of Quality of Life Among the General Population During the COVID-19 Pandemic.

Journal of clinical medicine·2025
Same author

Batch Synthesis of Primaquine Diphosphate Anti-Malarial Drug.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

Synthesis of Prilocaine Hydrochloride in Continuous Flow Systems.

ACS omega·2025
Same author

Exploring apprentice nursing associates' experiences of their home placements in primary care or social care.

Nursing management (Harrow, London, England : 1994)·2023
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
See all related articles

Microreactors accelerate drug discovery by enabling faster, more efficient synthesis and screening of novel chemical compounds. This technology offers a cost-neutral advantage for pharmaceutical companies seeking competitive edge in drug development.

Area of Science:

  • Pharmaceutical Science
  • Chemical Engineering
  • Drug Discovery

Background:

  • Pharmaceutical companies require rapid synthesis and screening of novel chemicals for new drug development.
  • Miniaturization of chemical reactors presents advantages for the pharmaceutical industry.
  • There is a constant search for controllable, information-rich, high-throughput, and environmentally friendly compound production methods.

Purpose of the Study:

  • To review the applications of microreactors in enhancing the drug discovery process.
  • To highlight the potential of microreactor technology for pharmaceutical research and development.

Main Methods:

  • Review of current and future applications of microreactors.
  • Analysis of advantages offered by miniaturized chemical reactors.

Related Experiment Videos

Main Results:

  • Microreactors offer fundamental and practical advantages for the pharmaceutical industry.
  • The technology supports controllable, information-rich, high-throughput, and environmentally friendly compound production.
  • Microreactors can enhance chemical selectivity in compound synthesis.

Conclusions:

  • Microreactor technology is poised to significantly enhance the speed and efficiency of drug discovery.
  • Adoption of microreactors can provide a competitive advantage to pharmaceutical companies.
  • Future applications of microreactors hold promise for a new generation of drug development.